Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZW4W
|
|||
Former ID |
DIB018067
|
|||
Drug Name |
(+)-JQ1
|
|||
Synonyms |
1268524-70-4; (+)-JQ-1; JQ1 compound; (+)-JQ1; JQ-1; UNII-1MRH0IMX0W; (S)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate; (S)-JQ1; 1MRH0IMX0W; JQ1; CHEMBL1957266; AK109409; (S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate; (S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate; (S)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Testicular cancer [ICD-11: 2C80] | Phase 1 | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C23H25ClN4O2S
|
|||
Canonical SMILES |
CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C
|
|||
InChI |
1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1
|
|||
InChIKey |
DNVXATUJJDPFDM-KRWDZBQOSA-N
|
|||
CAS Number |
CAS 1268524-70-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
99368178, 99368272, 104546758, 124361929, 124361931, 136380902, 136942413, 136969324, 137275912, 152258427, 160647263, 162109063, 163591148, 163632433, 164178323, 170483345, 170485027, 172441315, 172914699, 176245452, 184828707, 187051813, 198989400, 218907352, 223218678, 223391403, 223622031, 223705189, 225382496, 227149564, 249730472, 249855985, 250214062, 252071659, 252158115, 252160630, 252214001, 252445114
|
|||
ChEBI ID |
CHEBI:95080
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
Bromodomain testis-specific protein (BRDT) | Target Info | Inhibitor | [2] | |
Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [3] | |
KEGG Pathway | SNARE interactions in vesicular transport | |||
Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
WikiPathways | Chemical Compounds to monitor Proteins | |||
miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Small-molecule inhibition of BRDT for male contraception. Cell. 2012 Aug 17;150(4):673-84. | |||
REF 3 | Selective inhibition of BET bromodomains. Nature. 2010 Dec 23;468(7327):1067-73. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.